Overview

• The CE-marked wearable uses AI-driven Bayesian algorithms to personalize transcranial random noise stimulation parameters based on head anatomy and baseline attention without MRI.
• Peer-reviewed validation in npj Digital Medicine confirmed significant gains in sustained attention for participants receiving AI-tailored stimulation versus placebo or standard protocols.
• Home-based deployment over 290 sessions with 103 participants and a double-blind study of 37 volunteers reported no serious side effects or increased discomfort.
• Individuals with lower baseline focus experienced the largest improvements, indicating targeted benefits for users with attention deficits.
• Following CE approval, pilot programs are planned in educational, training, clinical environments while longer-term and broader population studies remain under consideration.